Around noon on Friday, March 8, 2024, Room 3073 at Stellenbosch University’s Biomedical Research Institute in South Africa was the venue for “Scientific Happy Hour,” a regular event of the Centre for Epidemic Response and Innovation.
During the session, the host, Tulio de Oliveira, who was recently named deputy director of the genomics surveillance unit at the Wellcome Sanger Institute, revealed his team adapted and successfully used their COVID-19 sequencing platform for dengue and chikungunya.
“It’s the same process and it worked. Those are the kind of things that we can learn,” de Oliveira said.
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Paul Adepojupauladepoju
Paul Adepoju is a Nigeria-based Devex Contributing Reporter, academic, and author. He covers health and tech in Africa for leading local and international media outlets including CNN, Quartz, and The Guardian. He's also the founder of healthnews.africa. He is completing a doctorate in cell biology and genetics and holds several reporting awards in health and tech.
